Using Biosensors in Cancer Drug Discovery
Author Information
Author(s): Kelly Tynan, Yang Xiaolong
Primary Institution: Queen’s University
Hypothesis
Biosensors can significantly enhance the drug discovery process in cancer research.
Conclusion
Biosensors have become essential tools in cancer drug discovery, providing real-time monitoring and insights into cancer biology.
Supporting Evidence
- Biosensors provide high sensitivity and specificity for monitoring cancer biomarkers.
- Fluorescence and bioluminescence-based biosensors have accelerated the identification of small-molecule inhibitors.
- Biosensors enable real-time monitoring of therapeutic efficacy in cancer treatments.
- Emerging trends include the integration of AI and advanced nanomaterials to enhance biosensor performance.
Takeaway
Biosensors are like special tools that help scientists see how cancer drugs work in real time, making it easier to find better treatments.
Methodology
The review discusses various biosensor technologies, including fluorescence and bioluminescence, and their applications in high-throughput screening for cancer drug discovery.
Limitations
Challenges include maintaining stability in complex tumor environments and achieving consistent sensitivity in high-throughput screening applications.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website